首页> 外文期刊>American journal of food technology >Toxicological Evaluation for Food Applications of Transglutaminase from a Newly Isolated Bacillus circulans BL32
【24h】

Toxicological Evaluation for Food Applications of Transglutaminase from a Newly Isolated Bacillus circulans BL32

机译:食品中新分离的环状芽孢杆菌BL32转谷氨酰胺酶食品应用的毒理学评估

获取原文
           

摘要

The present study aimed to submit the transglutaminase (TGase) from a Bacillus circulans strain isolated from the Amazon environment to in vivo and in vitro toxicological evaluations in order to assess its safety in food. The in vivo assay was assessed using male Wistar rats in a subacute 14 day oral feeding test using a liquid enzyme preparation administered to 150 U kg b.wt. day-1. The evaluation of cytotoxicity, genotoxicity and mutagenic effects of this microbial TGase was carried out using Chinese hamster lung fibroblasts cultured cells. No evidence of short term in vivo toxicity was found for the enzymatic preparation in the subacute 14 day oral toxicity study using white Wistar rats models, daily treated with 150 U kg b.wt. day-1 of TGase preparation. Furthermore, there were no statistical differences between the groups for relative weight gain and for hematological and clinical chemistry values. Histopathological examination of liver, kidneys, spleen, thymus, adrenal glands, heart, lungs and brain did not reveal any treatment-related changes. In addition, it was not verified any evidence of cytotoxicity, genotoxicity and mutagenic effects of the simple application of 150 U treatment-1 of this microbial TGase on Chinese hamster lung fibroblasts cultured cells. It can be concluded that no safety concerns were identified in this study for the BcTGase preparation produced under controlled cultivation conditions. Present results suggest that the microbial TGase from B. circulans BL32 is safe for food applications and has a potential for its industrial use.
机译:本研究旨在对从亚马逊环境分离的圆芽孢杆菌的转谷氨酰胺酶(TGase)进行体内和体外毒理学评估,以评估其在食品中的安全性。使用雄性Wistar大鼠在亚急性14天口服喂养试验中评估体内试验,该试验使用的液体酶制剂的剂量为150 U kgb.wt。天 -1 。使用中国仓鼠肺成纤维细胞培养的细胞对该微生物TGase的细胞毒性,遗传毒性和诱变作用进行评估。在每天使用150 U kg b.wt处理的白色Wistar大鼠模型的亚急性14天口服毒性研究中,没有发现酶制剂的短期体内毒性的证据。 TGase制备的第 -1 天。此外,两组之间相对体重增加以及血液学和临床化学值之间无统计学差异。肝,肾,脾,胸腺,肾上腺,心脏,肺和脑的组织病理学检查未发现任何与治疗相关的变化。此外,尚无任何证据证明简单应用这种微生物TGase 150 U处理 -1 对中国仓鼠肺成纤维细胞的细胞毒性,遗传毒性和诱变作用。可以得出结论,在这项研究中未发现在受控培养条件下生产的BcTGase制剂的安全性问题。目前的结果表明,来自圆环芽孢杆菌BL32的微生物TGase对于食品应用是安全的,并且具有工业应用的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号